Skip to content

Probiotics intervention in azithromycin for intestinal microecology in children with pneumonia

Probiotics intervention in azithromycin for intestinal microecology in children with pneumonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018471
Enrollment
Unknown
Registered
2018-09-20
Start date
2018-09-24
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mycoplasma pneumoniae pneumonia

Interventions

Group 2:Normal treatment without probiotics

Sponsors

Qilu Children's Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: Children with Mycoplasma pneumoniae admitted to the Department of Respiratory Medicine of Qilu Children's Hospital, the clinical diagnostic criteria refer to the "Children's Pneumococcal Pneumonia Expert Consensus" 2015 edition, severe and mild children with mycoplasma pneumonia treated with Azithromycin. It is included in children aged 3-14 years old in Jinan, Shandong Province and surrounding areas of Dezhou, Liaocheng, Jining, Heze, Zibo, Tai'an and Laiwu.

Exclusion criteria

Exclusion criteria: (1) cases of immunodeficiency diseases, tuberculosis and repeated respiratory infections; (2) Pathogenic examination of cases with bacterial and viral infections after admission; (3) Incomplete cases of clinical data that need to be intercepted in this paper; (4) Children with mycoplasmal pneumonia treated with other antibiotics; (5) Child patients who have used antibiotics within half a year.

Design outcomes

Primary

MeasureTime frame
16S rDNA;

Countries

China

Contacts

Public ContactMa Xiang

Ji'nan Children's Hospital

ubiome@126.com+86 15053100156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026